GRDN · NYSE · CIK 0001802255

Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc.’s most recent SEC filing in our snapshot is a Form 4 filed on Sep 28, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $1.4B and net income of $49.2M, according to its XBRL data on EDGAR. Its EDGAR record lists 45 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$1.4B
Net income, FY2025
$49.2M
Form 4 filings on record, past 12 months
45

Company overview

Legal name (as filed)
Guardian Pharmacy Services, Inc.
Ticker
GRDN
SEC Central Index Key (CIK)
0001802255
Business address
ATLANTA, GA
State or country of incorporation
GA
Fiscal year ends
December 31
SEC filer category
Accelerated filer
Position in SEC ticker list
#1821 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Guardian Pharmacy Services, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$1.2BFY2024$1.4BFY2025
Net income
-$110.0MFY2024$49.2MFY2025
GRDN annual results
ItemFY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$1.2B$1.4B
Net income-$110.0M$49.2M
Diluted EPS——
Total assets$320.8M$412.7M
Cash and equivalents$4.7M$65.6M

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

GRDN latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 11, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 6, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Sep 10, 20268-KOther events· period Sep 10, 2026Document · Index
Mar 26, 2026DEF 14ADefinitive proxy statement· period May 5, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Guardian Pharmacy Services, Inc., by form type:

4 ×213 ×78-K ×610-Q ×2SCHEDULE 13D/A ×1S-8 ×1S-3ASR ×1SCHEDULE 13G ×1
GRDN recent filings
FiledFormWhat it isOriginal
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 28, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 27, 2026Document · Index
Sep 10, 20268-KOther events· period Sep 10, 2026Document · Index
Aug 6, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 6, 20268-KResults of operations· period Aug 6, 2026Document · Index
Jun 22, 20268-KDirector or officer change; Regulation FD disclosure· period Jun 22, 2026Document · Index
May 28, 20268-KMaterial agreement; New financial obligation· period May 21, 2026Document · Index
May 7, 20264Statement of changes in beneficial ownership (insider trade)· period May 5, 2026Document · Index
May 7, 20264Statement of changes in beneficial ownership (insider trade)· period May 5, 2026Document · Index
May 7, 20264Statement of changes in beneficial ownership (insider trade)· period May 5, 2026Document · Index
May 7, 20268-KShareholder vote results· period May 5, 2026Document · Index
May 6, 2026S-8Registration of employee benefit plan securitiesDocument · Index
May 6, 2026S-3ASRSimplified registration statementDocument · Index
May 6, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 6, 20268-KResults of operations· period May 6, 2026Document · Index
May 6, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Apr 13, 20263Initial statement of beneficial ownership· period Apr 1, 2026Document · Index
Apr 13, 20263Initial statement of beneficial ownership· period Apr 1, 2026Document · Index
Apr 13, 20263Initial statement of beneficial ownership· period Apr 1, 2026Document · Index
Apr 13, 20263Initial statement of beneficial ownership· period Apr 1, 2026Document · Index
Apr 13, 20263Initial statement of beneficial ownership· period Apr 1, 2026Document · Index
Apr 13, 20263Initial statement of beneficial ownership· period Apr 1, 2026Document · Index
Apr 13, 20263Initial statement of beneficial ownership· period Apr 1, 2026Document · Index
Mar 31, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 28, 2026Document · Index
Mar 31, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 28, 2026Document · Index

Insider filing activity

45 Form 4 filings appear in Guardian Pharmacy Services, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Retail-Drug Stores and Proprietary Stores

All 2 companies in Retail-Drug Stores and Proprietary Stores· Companies headquartered in Georgia

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001802255 and XBRL company facts. Guardian Pharmacy Services, Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.